Updates in Heart Failure 2025

Chair: Gianluigi Savarese

Organized by: Karolinska Institute
in collaboration with Translational Medicine Academy (TMA)

December 15th-16th 2025

DECEMBER 15th 2025 (DAY 1)

Download Program

12.00-13.00

Lunch

13.00-13.05 

  • 13.00-13.05 | Greetings and introduction to the congress
    Gianluigi Savarese (SE)
Session 1: Translating guidelines into practice: Status of, barriers to and strategies to foster GDMT implementation

Chairs: Camilla Hage (SE), Robin Hofmann (SE) & Riccardo M. Inciardi (IT)

13.05-14.45

  • 13.05-13.15 | The gap between what guidelines say and what physicians do: The status of GDMT implementation worldwide
    Felix Lindber (SE)
  • 13.15-13.25 | Breaking down barriers: The point of view of the nephrologist on worsening renal function during GDMT
    James Burton (UK)
  • 13.25-13.35 | Breaking down barriers: Hyperkalemia – are we reaching a consensus for its management?
    Gianluigi Savarese (SE)
  • 13.35-13.45 | Breaking down barriers: Hypotension – when is it a real barrier?
    Nicolas Girerd (FR)
  • 13.45-13.55 | How to secure a fast and safe initiation of GDMT in clinical practice
    Alexandre Mebazaa (FR)
  • 13.55-14.05 | Worsening HF – which are the available weapons?
    Javed Butler (US)
  • 14.05-14.45 | Round Table: Ask the experts
    All

14.45-15-00

Coffee Break
Session 2: Treating cardio-renal-metabolic disease

Chairs: Magdy Abdelhamid (EG), James Burton (UK), Lars H. Lund (SE), & Giuseppe Rosano (UK)

15.00-16.30

  • 15.00-15.15 | CRM: The sizes of the problem
    Christian Basile (SE)
  • 15.15-15.30 | Mineralocorticoid receptor: An old and new target for treating CRM
    Scott Solomon (US)
  • 15.30-15.45 | The SGLT2i: Targeting T2DM, HF and CKD
    Javed Butler (US)
  • 15.45-16.00 | GLP1Ra: Targeting T2DM, CKD, obesity and HFpEF
    Mark Petrie (UK)
  • 16.00-16.30 | Round Table: Ask the experts
    All

16.30-16.50

Coffee Break
Session 3: Iron deficiency in HF 

Chairs: Carin Corovic-Cabrera (SE), Felix Lindberg (SE), Maurizio Volterrani (IT)

16.50-17.50

  • 16.50-17.00 | Iron deficiency in HF: A summary of evidence until 2024
    Gianluigi Savarese (SE)
  • 17.00-17.10 | FAIR-HF2: The last piece of evidence
    Stefan Anker (DE)
  • 17.10-17.20 | Any role for treating iron deficiency in HFpEF
    Stephan von Heahling (DE)
  • 17.20-17.30 | What is coming next
    John Cleland (UK)
  • 17.30-17.50 | Round Table: Ask the experts
    All
  • 17.55-18.00 | Closure of the day
    Gianluigi Savarese (SE)

December 16th 2025 (day 2 – morning)

  • 08.25-08.30 | Greetings
    Gianluigi Savarese (SE)
Session 4: Cardiac amyloidosis

08.30-09.30

Chairs: Leila Abid (TN), Per Eldhagen (SE), Riccardo M. Inciardi (IT), & Krister Lindmark (SE)

  • 08.30-08.40 | How to recognize a patient with cardiac amyloidosis
    Davide Stolfo (SE)
  • 08.40-08.50 | Advances in treatment: current and upcoming therapeutic options
    Peter van der Meer (NL)
  • 08.50-09:00 | Cardiac amyloidosis in clinical practice: Case-based discussion
    Antonio Cannata (UK)
  • 09.00-09:30 | Round Table: Ask the experts
    All
  • 09.30-09.55 | Lecture 1: Increasing patient adherence and addressing polypharmacy in patients with HF
    Chair: Gianluigi Savarese (SE), Speaker: Giuseppe Rosano (UK)

09.55-10.15

Coffee Break
Session 5: Not only pharmacological treatments: Devices!

Chairs: Andreas Rück (SE), Raffaele Scorza (SE), Bahira Shahim (SE) & Shelley Zieroth (CA)

10.15-11.45

  • 10.15-10.25 | Primary prophylactic ICD in HF: Towards precision medicine
    Frieder Braunschweig (SE)
  • 10.25-10.35 | CRT: When is OMT and time to proceed with implantation?
    Wilfried Mullens (BE)
  • 10.35-10.45 | TR: A treatment target in HF?
    Javed Butler (US)
  • 10.45-10.55 | Where do we stand for the treatment of FMR?
    Marianna Adamo (IT)
  • 10.55-11.05 | Treating aortic stenosis in HFrEF: When is it too late or too early?
    Stefan Blankenberg (SE)
  • 11.05-11.45 | Round Table: Ask the experts
    All

11.45-13.00

Lunch

December 16th 2025 (day 2 – afternoon)

  • 13.00-13.25 | Lecture 2: What can AI do for our HF patients?
    Chair: Folkert W. Asselbergs (NE), Speaker: Raffaele Scorza (SE)
Session 6: Recognizing advanced heart failure: The right timing and the right patients to refer

13.25-14.40

Chairs: Ovidiu Chioncel (RO), Lars H. Lunda (SE) & Michael Melin (SE)

  • 13.25-13.40 | How to manage GDMT in advanced HF
    Federica Guidetti (SE)
  • 13.40-14.00 | Diuretic resistance in advanced HF: Prevention, recognition, and treatment strategies
    Wilfried Mullens (BE)
  • 14.00-14.10 | Selecting the right candidates for transplant, LVAD, or palliative care
    Benedikt Schrage (DE)
  • 14.10-14.40 | Round Table: Ask the experts
    All
Session 7: Hypertrophic cardiomyopathy

14.40-15.30

Chairs: P Eldhagen (SE) & Gianluigi Savarese (SE)

  • 14.40-14.55 | HCM uncovered: From population patterns to precision diagnosis
    Antonio Cannata (UK)
  • 14.55-15.10 | Treating HCM yesterday, today, and tomorrow
    Iacopo Olivotto (IT)
  • 15.10-15.30 | Round Table: Ask the experts
    All
  • 15.30-16.00 | Lecture 3: Hot off the press and upcoming evidence 
    Chair: Gianluigi Savarese (SE), Speaker: Scott Solomon (US)
  • 16.00-16.05 | Closure of the day
    Gianluigi Savarese (SE)

Scroll to Top